These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7550119)

  • 1. Mechanism of anti-urease action by the anti-ulcer drug ecabet sodium.
    Ito Y; Hongo A; Kinoshita M; Tamaki H
    Biol Pharm Bull; 1995 Jun; 18(6):850-3. PubMed ID: 7550119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori.
    Ito Y; Shibata K; Hongo A; Kinoshita M
    Eur J Pharmacol; 1998 Mar; 345(2):193-8. PubMed ID: 9600637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
    Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O
    Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions.
    Shibata K; Ito Y; Hongo A; Yasoshima A; Endo T; Ohashi M
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1295-9. PubMed ID: 7574519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori.
    Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y
    Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein.
    Ito Y; Onoda Y; Nakamura S; Tagawa K; Fukushima T; Sugawara Y; Takaiti O
    Jpn J Pharmacol; 1993 Jun; 62(2):175-81. PubMed ID: 8371516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ecabet sodium].
    Takahashi S; Tanaka A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():711-6. PubMed ID: 11979876
    [No Abstract]   [Full Text] [Related]  

  • 8. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
    Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yokota K; Isogai H; Isogai E; Shimomura H; Oguma K; Asaka M; Hirai Y
    Microbiol Immunol; 2000; 44(7):557-62. PubMed ID: 10981828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
    Shimoyama T; Fukuda S; Liu Q; Nakaji S; Munakata A; Sugawara K
    J Gastroenterol; 2001 Mar; 36(3):153-7. PubMed ID: 11291877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent.
    Kinoshita M; Tamaki H
    Dig Dis Sci; 1997 Jan; 42(1):83-90. PubMed ID: 9009120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro.
    Furukawa O; Kume E; Sugamoto S; Kawauchi S; Takeuchi K
    Digestion; 2000; 62(2-3):116-25. PubMed ID: 11025359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.
    Koizumi W; Tanabe S; Imaizumi H; Kida M; Ohida M; Koshida Y; Mitomi H; Hosaka Y; Nagaba S; Sasaki T; Higuchi K; Saigenji K
    Hepatogastroenterology; 2003; 50(50):577-81. PubMed ID: 12749277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells.
    Kusumoto K; Kawahara T; Kuwano Y; Teshima-Kondo S; Morita K; Kishi K; Rokutan K
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G300-7. PubMed ID: 15458921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yachi A; Yokota K; Hirai Y; Oguma K; Fujii N
    J Gastroenterol; 1997 Oct; 32(5):593-7. PubMed ID: 9349983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
    Kinoshita M; Endo M; Yasoshima A; Saito N; Yamasaki K; Chishima S; Narita H
    Aliment Pharmacol Ther; 1999 May; 13(5):687-94. PubMed ID: 10233194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ecabet sodium treatment on urea breath test and stool antigen tests in volunteers with Helicobacter pylori infection.
    Okuda M; Yamamoto N; Fukuda N; Maekawa K; Kusaka T; Hashimoto M; Kotake J; Koizuka H; Fukuda Y
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():100-2. PubMed ID: 22486880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.
    Ichikawa T; Ishihara K; Hayashida H; Hiruma H; Saigenji K; Hotta K
    Dig Dis Sci; 2000 Mar; 45(3):606-13. PubMed ID: 10749340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.
    Kinoshita M; Kume E; Tamaki H
    J Pharmacol Exp Ther; 1995 Oct; 275(1):494-501. PubMed ID: 7562591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.